Logo image
Impact of Comorbidities on Survival among American Indian and Alaska Native People with Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Study
Journal article   Peer reviewed

Impact of Comorbidities on Survival among American Indian and Alaska Native People with Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Study

Sarah H Nash, Bradley T Loeffler, Jennifer Erdrich, Elizabeth Verhage, Jamie Sorensen, Vanessa E Slater, Faith Elenwa, Jerreed D Ivanich, Brian J Smith, Keely K Ulmer, …
Cancer epidemiology, biomarkers & prevention
06/02/2026
DOI: 10.1158/1055-9965.EPI-26-0182
PMID: 42227960

View Online

Abstract

American Indian and Alaska Native (AIAN) people experience lower cancer survival than other racial/ethnic groups for several cancer sites. We explored predictors of cancer survival among AIAN people, with a specific focus on the potential impact of comorbidities. We analyzed Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data. AIAN people diagnosed with breast (female only), lung, and colorectal cancers from 2000-2019, aged 66+ years at diagnosis, and with at least one year of Medicare coverage prior to diagnosis were included in the study. We used multivariable-adjusted Cox proportional hazards models to assess associations of comorbidity class, previously defined using latent class analysis, with overall and cancer-specific survival, adjusted for sociodemographic characteristics and area-based social measures. The sample included 831 individuals with female breast cancer, 1009 individuals with colorectal cancer, and 1195 individuals with lung cancer. Comorbidity class was associated with five-year hazard of death from any cause for breast and colorectal cancer, but not lung cancer patients. Further, we only observed associations of comorbidity class with five-year cancer-specific death for lung cancer, where the class associated with heart and vascular-related conditions experienced increased hazard of death. Higher comorbidity prevalence among AIAN people compared to other racial/ethnic groups did not contribute to observed disparities in cancer-specific survival; however, AIAN people with comorbid conditions may be more likely to experience death from any cause than those without these conditions. Differences in prevalence of comorbid conditions are unlikely to drive disparities in cancer-specific survival observed among AIAN peoples.

Details

Logo image